<table> 
<tbody>
<tr><th>Rank</th><th>Pathway</th><th>q-value</th></tr>
<tr><td>1</td><td>NS1 Mediated Effects on Host Pathways</td><td>1e-05</td></tr>
<tr><td>2</td><td>Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell</td><td>1e-05</td></tr>
<tr><td>3</td><td>Host Interactions of HIV factors</td><td>1e-05</td></tr>
<tr><td>4</td><td>Metabolism of polyamines</td><td>1e-05</td></tr>
<tr><td>5</td><td>Mitotic Spindle Checkpoint</td><td>1e-05</td></tr>
<tr><td>6</td><td>Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal</td><td>1e-05</td></tr>
<tr><td>7</td><td>Amplification of signal from the kinetochores</td><td>1e-05</td></tr>
<tr><td>8</td><td>Assembly of the pre-replicative complex</td><td>1e-05</td></tr>
<tr><td>9</td><td>tRNA processing</td><td>1e-05</td></tr>
<tr><td>10</td><td>DNA Replication</td><td>1e-05</td></tr>
<tr><td>11</td><td>RHO GTPase Effectors</td><td>1e-05</td></tr>
<tr><td>12</td><td>EML4 and NUDC in mitotic spindle formation</td><td>1e-05</td></tr>
<tr><td>13</td><td>tRNA processing in the nucleus</td><td>1e-05</td></tr>
<tr><td>14</td><td>Mitotic Anaphase</td><td>1e-05</td></tr>
<tr><td>15</td><td>Antigen processing-Cross presentation</td><td>1e-05</td></tr>
<tr><td>16</td><td>Cell Cycle Checkpoints</td><td>1e-05</td></tr>
<tr><td>17</td><td>Resolution of Sister Chromatid Cohesion</td><td>1e-05</td></tr>
<tr><td>18</td><td>Separation of Sister Chromatids</td><td>1e-05</td></tr>
<tr><td>19</td><td>Mitotic Metaphase and Anaphase</td><td>1e-05</td></tr>
<tr><td>20</td><td>EPHB-mediated forward signaling</td><td>1e-05</td></tr>
<tr><td>21</td><td>Host Interactions with Influenza Factors</td><td>1e-05</td></tr>
<tr><td>22</td><td>RHO GTPases Activate Formins</td><td>1e-05</td></tr>
<tr><td>23</td><td>Cell Cycle, Mitotic</td><td>1e-05</td></tr>
<tr><td>24</td><td>DNA Replication Pre-Initiation</td><td>1e-05</td></tr>
<tr><td>25</td><td>G2/M Checkpoints</td><td>1e-05</td></tr>
<tr><td>26</td><td>ER-Phagosome pathway</td><td>1e-05</td></tr>
<tr><td>27</td><td>Synthesis of DNA</td><td>1e-05</td></tr>
<tr><td>28</td><td>Orc1 removal from chromatin</td><td>1e-05</td></tr>
<tr><td>29</td><td>APC/C:Cdc20 mediated degradation of mitotic proteins</td><td>3.781666603504981e-05</td></tr>
<tr><td>30</td><td>Mitotic G1 phase and G1/S transition</td><td>3.892892091843369e-05</td></tr>
<tr><td>31</td><td>CDT1 association with the CDC6:ORC:origin complex</td><td>4.010858518868915e-05</td></tr>
<tr><td>32</td><td>Regulation of ornithine decarboxylase (ODC)</td><td>4.13619784758357e-05</td></tr>
<tr><td>33</td><td>Nuclear Envelope Breakdown</td><td>4.269623584602394e-05</td></tr>
<tr><td>34</td><td>M Phase</td><td>4.4119443707558185e-05</td></tr>
<tr><td>35</td><td>FCGR activation</td><td>4.56408038354049e-05</td></tr>
<tr><td>36</td><td>Transport of the SLBP Dependant Mature mRNA</td><td>6.302777672508298e-05</td></tr>
<tr><td>37</td><td>S Phase</td><td>6.456503957203628e-05</td></tr>
<tr><td>38</td><td>Transport of Mature mRNA Derived from an Intronless Transcript</td><td>6.617916556133716e-05</td></tr>
<tr><td>39</td><td>Creation of C4 and C2 activators</td><td>6.787606724239706e-05</td></tr>
<tr><td>40</td><td>Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC)</td><td>6.966227953824967e-05</td></tr>
<tr><td>41</td><td>G1/S DNA Damage Checkpoints</td><td>7.154504385009411e-05</td></tr>
<tr><td>42</td><td>p53-Dependent G1/S DNA damage checkpoint</td><td>7.353240617926345e-05</td></tr>
<tr><td>43</td><td>SUMOylation of chromatin organization proteins</td><td>8.272395695167142e-05</td></tr>
<tr><td>44</td><td>p53-Independent DNA Damage Response</td><td>8.448404114213249e-05</td></tr>
<tr><td>45</td><td>Classical antibody-mediated complement activation</td><td>8.63206507321789e-05</td></tr>
<tr><td>46</td><td>The role of GTSE1 in G2/M progression after G2 checkpoint</td><td>8.823888741511621e-05</td></tr>
<tr><td>47</td><td>Rev-mediated nuclear export of HIV RNA</td><td>9.024431667455064e-05</td></tr>
<tr><td>48</td><td>Cell Cycle</td><td>9.234302171349364e-05</td></tr>
<tr><td>49</td><td>Endosomal/Vacuolar pathway</td><td>9.989308009258461e-05</td></tr>
<tr><td>50</td><td>MHC class II antigen presentation</td><td>0.0001018141008635956</td></tr>
</tbody> 
</table>